Drug repurposing against COVID-19: focus on anticancer agents

The very limited time allowed to face the COVID-19 pandemic poses a pressing challenge to find proper therapeutic approaches. However, synthesis and full investigation from preclinical studies to phase III tri...

Source: Journal of Experimental and Clinical Cancer Research - May 12, 2020 Category: Cancer & Oncology Authors: Gennaro Ciliberto, Rita Mancini and Marco G. Paggi Tags: Review Source Type: research